Literature DB >> 25932145

Correlation between triggering receptor expressed on myeloid cells-1 and clinical disease activity in Chinese patients with ulcerative colitis.

Shulan Zhang1, Jing Luo2, Bingbing Shen3, Lijun Li1, Chaojun Hu1, Ping Li1, Chuiwen Deng1, Fengchun Zhang1, Jiaming Qian4, Yongzhe Li1.   

Abstract

The need for reliable biomarkers for monitoring disease activity in patients with ulcerative colitis (UC) is increasing. This study aimed at characterizing the correlation between serum sTREM-1 levels and diseases activity in Chinese patients with UC. Consecutive 76 patients with UC and 20 healthy subjects were prospectively enrolled. The disease activity of UC was assessed according to Mayo Score. Expression levels of TREM-1 in peripheral blood mononuclear cells (PBMCs) and serum sTREM-1 levels were evaluated at the time when the disease activity was determined. Other laboratory parameters, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were also determined. Both TREM-1 expression levels in PBMCs and serum sTREM-1 levels from patients with UC were significantly increased compared to healthy subjects. In addition, the levels of TREM-1 expression and serum sTREM-1 were significantly elevated in UC patients with moderate or severe disease compared to the patients with quiescent or mild disease. More importantly, both levels of TREM-1 expression in PBMCs and serum sTREM-1 levels were significantly correlated with disease activity. The correlation between sTREM-1 and disease activity was higher than the correlations between CRP and disease activity or ESR and disease activity. Our findings suggest that serum sTREM-1 could be a potential serum biomarker for monitoring disease activity in Chinese patients with UC, and could be a promising surrogate for CRP and ESR.

Entities:  

Keywords:  Chinese patients; Ulcerative colitis (UC); disease activity; sTREM-1; triggering receptor expressed on myeloid cells-1 (TREM-1)

Year:  2015        PMID: 25932145      PMCID: PMC4402792     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

1.  Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease.

Authors:  Michalis Tzivras; Vassilios Koussoulas; Evangelos J Giamarellos-Bourboulis; Dimitrios Tzivras; Thomas Tsaganos; Pantelis Koutoukas; Helen Giamarellou; Athanasios Archimandritis
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

2.  Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet's disease.

Authors:  Yoon Suk Jung; Seung Won Kim; Jin Young Yoon; Jin Ha Lee; Soung Min Jeon; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Inflamm Bowel Dis       Date:  2011-01-06       Impact factor: 5.325

Review 3.  The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

Authors:  James D Lewis
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

4.  Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis.

Authors:  C E Collins; D T La; H-T Yang; F Massin; S Gibot; G Faure; W Stohl
Journal:  Ann Rheum Dis       Date:  2008-12-03       Impact factor: 19.103

5.  TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines.

Authors:  Jun Kuai; Bernard Gregory; Andrew Hill; Debra D Pittman; Jeffrey L Feldman; Tom Brown; Brenda Carito; Margot O'Toole; Renee Ramsey; Oskar Adolfsson; Kathleen M Shields; Ken Dower; J Perry Hall; Yahya Kurdi; Jonathan T Beech; Jagdeep Nanchahal; Marc Feldmann; Brian M Foxwell; Fionula M Brennan; David G Winkler; Lih-Ling Lin
Journal:  Rheumatology (Oxford)       Date:  2009-08-27       Impact factor: 7.580

6.  TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.

Authors:  Mirjam Schenk; Axel Bouchon; Frank Seibold; Christoph Mueller
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

7.  Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.

Authors:  Yousuke Murakami; Tohru Akahoshi; Naoko Aoki; Masayasu Toyomoto; Nobuyuki Miyasaka; Hitoshi Kohsaka
Journal:  Arthritis Rheum       Date:  2009-06

8.  Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease.

Authors:  Jae Jun Park; Jae Hee Cheon; Bo Young Kim; Duk Hwan Kim; Eun Soo Kim; Tae Il Kim; Kyoung Ryul Lee; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

Review 9.  Laboratory markers in IBD: useful, magic, or unnecessary toys?

Authors:  S Vermeire; G Van Assche; P Rutgeerts
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

Review 10.  Inflammatory bowel disease: clinical aspects and treatments.

Authors:  Marc Fakhoury; Rebecca Negrulj; Armin Mooranian; Hani Al-Salami
Journal:  J Inflamm Res       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.